Title:
ホルモン感受性リパーゼの活性を低下させるための化合物の使用
Document Type and Number:
Japanese Patent JP2005518377
Kind Code:
A
Abstract:
Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
Inventors:
Evdorp, Soren
Hansen, Holgel Klaus
Bedoso, Pell
Cornelis de John, Johannes
Jacobsen, Paul
Hansen, Holgel Klaus
Bedoso, Pell
Cornelis de John, Johannes
Jacobsen, Paul
Application Number:
JP2003552729A
Publication Date:
June 23, 2005
Filing Date:
December 13, 2002
Export Citation:
Assignee:
NOVO NORDISK AKTIE SELSXAB
International Classes:
A61K31/16; A61K31/27; A61K31/275; A61K31/341; A61K31/343; A61K31/352; A61K31/37; A61K31/381; A61K31/40; A61K31/401; A61K31/4015; A61K31/4035; A61K31/4045; A61K31/407; A61K31/41; A61K31/415; A61K31/4155; A61K31/4164; A61K31/4184; A61K31/4192; A61K31/4196; A61K31/423; A61K31/426; A61K31/428; A61K31/437; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4439; A61K31/444; A61K31/445; A61K31/451; A61K31/4545; A61K31/455; A61K31/465; A61K31/47; A61K31/4709; A61K31/472; A61K31/4725; A61K31/473; A61K31/495; A61K31/496; A61K31/498; A61K31/4995; A61K31/50; A61K31/505; A61K31/5375; A61K31/5377; A61K31/541; A61K31/55; A61K31/551; A61K31/63; A61K45/00; A61P1/04; A61P1/18; A61P3/04; A61P3/06; A61P3/10; A61P5/50; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P17/06; A61P21/04; A61P25/16; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/18; A61P35/00; A61P43/00; C07C39/367; C07C233/25; C07C233/26; C07C233/60; C07C269/00; C07C271/58; C07C275/34; C07C303/34; C07C303/38; C07C307/06; C07D249/08; C07C311/04; C07C311/17; C07C311/21; C07C311/29; C07C311/40; C07C317/22; C07C323/20; C07D207/325; C07D207/36; C07D207/40; C07D207/404; C07D209/08; C07D209/32; C07D209/48; C07D211/40; C07D211/88; C07D213/61; C07D213/63; C07D213/64; C07D213/643; C07D213/65; C07D213/68; C07D213/69; C07D213/70; C07D213/74; C07D213/75; C07D213/82; C07D213/84; C07D215/14; C07D215/20; C07D215/22; C07D217/06; C07D217/24; C07D221/14; C07D231/12; C07D231/14; C07D231/16; C07D231/18; C07D233/54; C07D233/60; C07D233/70; C07D233/84; C07D235/18; C07D235/26; C07D237/14; C07D239/22; C07D239/34; C07D239/38; C07D241/18; C07D241/44; C07D249/04; C07D249/12; C07D249/18; C07D253/04; C07D257/04; C07D261/12; C07D261/20; C07D263/52; C07D277/20; C07D277/24; C07D277/34; C07D277/68; C07D285/00; C07D285/01; C07D295/18; C07D295/20; C07D295/205; C07D295/26; C07D307/16; C07D307/28; C07D307/52; C07D307/89; C07D311/16; C07D311/18; C07D333/16; C07D333/32; C07D333/34; C07D333/40; C07D401/04; C07D401/12; C07D401/14; C07D403/12; C07D405/12; C07D405/14; C07D409/04; C07D409/12; C07D413/12; C07D417/12; C07D471/04; C07D471/06; C07D487/08; C07D487/18; C07D491/10; C07D513/04; C07D521/00; (IPC1-7): A61K31/27; A61K31/343; A61K31/37; A61K31/381; A61K31/401; A61K31/4015; A61K31/4035; A61K31/4045; A61K31/415; A61K31/4164; A61K31/4184; A61K31/4192; A61K31/4196; A61K31/423; A61K31/426; A61K31/428; A61K31/437; A61K31/44; A61K31/445; A61K31/47; A61K31/4709; A61K31/4725; A61K31/495; A61K31/496; A61K31/498; A61K31/4995; A61K31/505; A61K31/5375; A61K31/5377; A61K31/551; A61K45/00; A61P1/04; A61P1/18; A61P3/04; A61P3/06; A61P3/10; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P17/06; A61P21/04; A61P25/16; A61P25/22; A61P25/24; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/18; A61P35/00; A61P43/00; C07D215/20
Attorney, Agent or Firm:
Takehiko Suzue
Satoshi Kono
Makoto Nakamura
Sadao Muramatsu
Ryo Hashimoto
Satoshi Kono
Makoto Nakamura
Sadao Muramatsu
Ryo Hashimoto